Takaji Wakita

Takaji Wakita's AcademicInfluence.com Rankings

Takaji Wakita

Biology

#9218

World Rank

#12395

Historical Rank

Virology

#211

World Rank

#218

Historical Rank

Immunology

#547

World Rank

#565

Historical Rank

biology Degrees

Download Badge

Biology

Takaji Wakita's Degrees

PhD Medical Science University of Tokyo
Doctorate Medicine University of Tokyo

Why Is Takaji Wakita Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Takaji Wakita's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome (2005) (2882)
Robust hepatitis C virus infection in vitro. (2005) (1828)
The lipid droplet is an important organelle for hepatitis C virus production (2007) (1211)
Detection of hepatitis C virus by polymerase chain reaction and response to interferon‐α therapy: Relationship to genotypes of hepatitis C virus (1992) (656)
Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. (2003) (634)
Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis (2006) (615)
Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells (2006) (384)
Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71 (2009) (376)
Interaction of Hepatitis C Virus Nonstructural Protein 5A with Core Protein Is Critical for the Production of Infectious Virus Particles (2008) (370)
The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus. (2015) (353)
Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response (2008) (336)
Closed environments facilitate secondary transmission of coronavirus disease 2019 (COVID-19) (2020) (292)
Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81 (2007) (280)
Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient * (2001) (269)
Apolipoprotein B–dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin (2008) (258)
Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP. (2014) (253)
Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. (1996) (251)
DDX3 DEAD-Box RNA Helicase Is Required for Hepatitis C Virus RNA Replication (2007) (250)
Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP) (2014) (214)
Subcellular Localization of Hepatitis C Virus Structural Proteins in a Cell Culture System That Efficiently Replicates the Virus (2006) (209)
Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection (2008) (193)
Cell culture and infection system for hepatitis C virus (2006) (186)
Knockdown of autophagy-related gene decreases the production of infectious Hepatitis C virus particles (2009) (175)
Robust Production of Infectious Hepatitis C Virus (HCV) from Stably HCV cDNA-Transfected Human Hepatoma Cells (2005) (173)
Molecular biology of hepatitis C virus (2007) (172)
Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes. (2010) (165)
Noroviruses Distinguish between Type 1 and Type 2 Histo-Blood Group Antigens for Binding (2008) (162)
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans (2013) (161)
Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication (2006) (154)
Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. (1992) (153)
Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins. (2007) (153)
Hepatitis C viral life cycle. (2007) (151)
Hepatitis C Virus Nonstructural 4B Protein Modulates Sterol Regulatory Element-binding Protein Signaling via the AKT Pathway* (2009) (142)
Structure of Hepatitis E Virion-sized Particle Reveals an RNA-dependent Viral Assembly Pathway* (2010) (141)
Nonhepatic Cell Lines HeLa and 293 Support Efficient Replication of the Hepatitis C Virus Genotype 2a Subgenomic Replicon (2005) (140)
Phosphatidylinositol 4-Kinase III Beta Is a Target of Enviroxime-Like Compounds for Antipoliovirus Activity (2010) (137)
An Attenuated Strain of Enterovirus 71 Belonging to Genotype A Showed a Broad Spectrum of Antigenicity with Attenuated Neurovirulence in Cynomolgus Monkeys (2007) (135)
CD81 Expression Is Important for the Permissiveness of Huh7 Cell Clones for Heterogeneous Hepatitis C Virus Infection (2007) (133)
Infectivity of Hepatitis C Virus Is Influenced by Association with Apolipoprotein E Isoforms (2010) (132)
Nuclear Localization of Japanese Encephalitis Virus Core Protein Enhances Viral Replication (2005) (132)
Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization (2019) (131)
Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells. (2010) (130)
Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. (1993) (129)
A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitis C. (1993) (128)
miR-122 Stimulates Hepatitis C Virus RNA Synthesis by Altering the Balance of Viral RNAs Engaged in Replication versus Translation (2015) (126)
Genotype 2a Hepatitis C Virus Subgenomic Replicon Can Replicate in HepG2 and IMY-N9 Cells* (2004) (126)
Upregulation of Indoleamine 2,3-Dioxygenase in Hepatitis C Virus Infection (2007) (125)
Hepatitis C Virus Reveals a Novel Early Control in Acute Immune Response (2011) (119)
Initial Investigation of Transmission of COVID-19 Among Crew Members During Quarantine of a Cruise Ship — Yokohama, Japan, February 2020 (2020) (118)
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies. (2018) (117)
Production of Infectious Hepatitis C Virus of Various Genotypes in Cell Cultures (2007) (116)
Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides. In vitro model for selection of target sequence. (1994) (116)
Interleukin-1 and Tumor Necrosis Factor-α Trigger Restriction of Hepatitis B Virus Infection via a Cytidine Deaminase Activation-induced Cytidine Deaminase (AID)* (2013) (114)
E6AP Ubiquitin Ligase Mediates Ubiquitylation and Degradation of Hepatitis C Virus Core Protein (2006) (113)
NTCP and Beyond: Opening the Door to Unveil Hepatitis B Virus Entry (2014) (113)
Hepatitis C Virus Controls Interferon Production through PKR Activation (2010) (113)
Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan (2021) (112)
Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells (2018) (112)
Efficient Conditional Transgene Expression in Hepatitis C Virus cDNA Transgenic Mice Mediated by the Cre/loxP System* (1998) (111)
Antiviral Lectins from Red and Blue-Green Algae Show Potent In Vitro and In Vivo Activity against Hepatitis C Virus (2012) (108)
Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro (2013) (107)
Cooperative Effect of the Attenuation Determinants Derived from Poliovirus Sabin 1 Strain Is Essential for Attenuation of Enterovirus 71 in the NOD/SCID Mouse Infection Model (2007) (106)
Replication of a hepatitis C virus replicon clone in mouse cells (2006) (104)
Generation of Infectious Hepatitis C Virus in Immortalized Human Hepatocytes (2006) (101)
Oxysterol-Binding Protein Family I Is the Target of Minor Enviroxime-Like Compounds (2013) (98)
Enterovirus 71 Binding to PSGL-1 on Leukocytes: VP1-145 Acts as a Molecular Switch to Control Receptor Interaction (2013) (96)
Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein (2010) (96)
Expression and immune response to hepatitis C virus core DNA–based vaccine constructs (1996) (95)
Visualization and Measurement of ATP Levels in Living Cells Replicating Hepatitis C Virus Genome RNA (2012) (94)
Detection of pre-C and core region mutants of hepatitis B virus in chronic hepatitis B virus carriers. (1991) (94)
Hepatitis virus infection affects DNA methylation in mice with humanized livers. (2014) (94)
Detection of Anti-Hepatitis C Virus Effects of Interferon and Ribavirin by a Sensitive Replicon System (2005) (92)
Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity (2016) (91)
Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity. (2008) (91)
Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment (2021) (90)
The ESCRT System Is Required for Hepatitis C Virus Production (2011) (88)
Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants (2021) (88)
Hepatitis C virus triggers Golgi fragmentation and autophagy through the immunity-related GTPase M (2017) (87)
Regulation of Hepatitis C Virus Replication by Interferon Regulatory Factor 1 (2004) (87)
Role of the Endoplasmic Reticulum-associated Degradation (ERAD) Pathway in Degradation of Hepatitis C Virus Envelope Proteins and Production of Virus Particles* (2011) (85)
Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone. (2005) (85)
The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles (2007) (84)
Involvement of Hepatitis C Virus NS5A Hyperphosphorylation Mediated by Casein Kinase I-α in Infectious Virus Production (2014) (83)
Human sapovirus classification based on complete capsid nucleotide sequences (2012) (83)
25‐hydroxyvitamin D3 suppresses hepatitis C virus production (2012) (83)
Hepatitis C virus–infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells (2008) (82)
Apoptosis in cultured rat hepatocytes: The effects of tumour necrosis factor α and interferon γ (1991) (81)
Formation of covalently closed circular DNA in Hep38.7-Tet cells, a tetracycline inducible hepatitis B virus expression cell line. (2014) (78)
Novel robust in vitro hepatitis B virus infection model using fresh human hepatocytes isolated from humanized mice. (2015) (78)
Tyrosine Sulfation of the Amino Terminus of PSGL-1 Is Critical for Enterovirus 71 Infection (2010) (77)
The DNA Damage Sensors Ataxia-Telangiectasia Mutated Kinase and Checkpoint Kinase 2 Are Required for Hepatitis C Virus RNA Replication (2008) (74)
Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus (2018) (74)
Regulation of CXCL-8 (Interleukin-8) Induction by Double-Stranded RNA Signaling Pathways during Hepatitis C Virus Infection (2006) (74)
Surveillance of pathogens in outpatients with gastroenteritis and characterization of sapovirus strains between 2002 and 2007 in Kumamoto Prefecture, Japan (2009) (73)
Neutralizing antibodies induced by cell culture-derived hepatitis C virus protect against infection in mice. (2013) (71)
Amphipathic α-Helices in Apolipoproteins Are Crucial to the Formation of Infectious Hepatitis C Virus Particles (2014) (71)
Characterization of self-assembled virus-like particles of rat hepatitis E virus generated by recombinant baculoviruses (2011) (71)
Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development. (2019) (69)
Sphingomyelin Activates Hepatitis C Virus RNA Polymerase in a Genotype-Specific Manner (2010) (66)
A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide (2015) (65)
Hepatitis C virus JFH‐1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation (2008) (64)
Multidrug treatment with nelfinavir and cepharanthine against COVID-19 (2020) (64)
Rapid and real-time detection of hepatitis A virus by reverse transcription loop-mediated isothermal amplification assay. (2007) (64)
The NS3 Helicase and NS5B-to-3′X Regions Are Important for Efficient Hepatitis C Virus Strain JFH-1 Replication in Huh7 Cells (2007) (63)
Proteasomal Turnover of Hepatitis C Virus Core Protein Is Regulated by Two Distinct Mechanisms: a Ubiquitin-Dependent Mechanism and a Ubiquitin-Independent but PA28γ-Dependent Mechanism (2008) (63)
High prevalence of rat hepatitis E virus in wild rats in China. (2013) (61)
Lipoprotein Receptors Redundantly Participate in Entry of Hepatitis C Virus (2016) (61)
Haplotype networks of SARS-CoV-2 infections in the Diamond Princess cruise ship outbreak (2020) (61)
Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon (2007) (59)
Hepatitis B core antigen-specific IFN-gamma production of peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection. (1989) (59)
Intragenotypic JFH1 based recombinant hepatitis C virus produces high levels of infectious particles but causes increased cell death. (2008) (59)
Development of a Rapid High-Throughput Method for High-Resolution Melting Analysis for Routine Detection and Genotyping of Noroviruses (2008) (58)
Structural Basis for the Recognition of Lewis Antigens by Genogroup I Norovirus (2012) (58)
Chaperonin TRiC/CCT participates in replication of hepatitis C virus genome via interaction with the viral NS5B protein. (2011) (57)
Replication of hepatitis C virus genotype 3a in cultured cells. (2013) (57)
A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins (2017) (57)
Characterization of three novel monoclonal antibodies against hepatitis C virus core protein (1996) (57)
Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship (2020) (57)
Valosin-Containing Protein (VCP/p97) Is Required for Poliovirus Replication and Is Involved in Cellular Protein Secretion Pathway in Poliovirus Infection (2012) (57)
RNA Polymerase Activity and Specific RNA Structure Are Required for Efficient HCV Replication in Cultured Cells (2010) (56)
The Role of VP1 Amino Acid Residue 145 of Enterovirus 71 in Viral Fitness and Pathogenesis in a Cynomolgus Monkey Model (2015) (56)
Serum interleukin 6 levels in patients with chronic hepatitis B. (1991) (55)
Interferon gamma production by peripheral blood lymphocytes to hepatitis C virus core protein in chronic hepatitis C infection (1995) (54)
Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis C. (2011) (53)
Differential cellular and humoral immune responses to HCV core and HBV envelope proteins after genetic immunizations using chimeric constructs. (1998) (53)
Hepatitis C Virus Infection Sensitizes Human Hepatocytes to TRAIL-Induced Apoptosis in a Caspase 9-Dependent Manner1 (2008) (53)
Dysregulation of Retinoic Acid Receptor Diminishes Hepatocyte Permissiveness to Hepatitis B Virus Infection through Modulation of Sodium Taurocholate Cotransporting Polypeptide (NTCP) Expression* (2014) (52)
2',5'-Oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitro. (2010) (51)
Comparison between Subgenomic Replicons of Hepatitis C Virus Genotypes 2a (JFH-1) and 1b (Con1 NK5.1) (2005) (51)
Ethanol Enhances Hepatitis C Virus Replication through Lipid Metabolism and Elevated NADH/NAD+* (2009) (51)
Cellular kinase inhibitors that suppress enterovirus replication have a conserved target in viral protein 3A similar to that of enviroxime. (2009) (51)
Identification of annexin A1 as a novel substrate for E6AP‐mediated ubiquitylation (2009) (49)
Rab18 is required for viral assembly of hepatitis C virus through trafficking of the core protein to lipid droplets. (2014) (49)
Development of hepatitis C virus genotype 3a cell culture system (2014) (48)
Monoclonal Antibodies against Extracellular Domains of Claudin-1 Block Hepatitis C Virus Infection in a Mouse Model (2015) (47)
Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system. (2011) (47)
Hepatitis E Virus Outbreak in Monkey Facility, Japan (2012) (47)
Genetic Variation of the IL-28B Promoter Affecting Gene Expression (2011) (47)
Susceptibility of laboratory rats against genotypes 1, 3, 4, and rat hepatitis E viruses. (2013) (46)
A bifunctional anti-enterovirus compound that inhibits replication and the early stage of enterovirus 71 infection. (2010) (46)
Production of infectious dromedary camel hepatitis E virus by a reverse genetic system: Potential for zoonotic infection. (2016) (46)
Novel Cell Culture-Adapted Genotype 2a Hepatitis C Virus Infectious Clone (2012) (46)
Selective estrogen receptor modulators inhibit hepatitis C virus infection at multiple steps of the virus life cycle. (2013) (46)
Hepatitis C virus infection of T cells inhibits proliferation and enhances fas-mediated apoptosis by down-regulating the expression of CD44 splicing variant 6. (2009) (46)
Genotype 5 Hepatitis E Virus Produced by a Reverse Genetics System Has the Potential for Zoonotic Infection (2018) (45)
Immunohistochemical studies of intrahepatic tumour necrosis factor alpha in chronic liver disease. (1990) (45)
Primary hepatocyte culture supports hepatitis C virus replication: A model for infection‐associated hepatocarcinogenesis (2010) (44)
De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular Entry. (2018) (44)
Signal Peptidase Complex Subunit 1 Participates in the Assembly of Hepatitis C Virus through an Interaction with E2 and NS2 (2013) (44)
Production of Infectious Hepatitis C Virus by Using RNA Polymerase I-Mediated Transcription (2010) (44)
Efficient replication systems for hepatitis C virus using a new human hepatoma cell line. (2009) (44)
Involvement of Creatine Kinase B in Hepatitis C Virus Genome Replication through Interaction with the Viral NS4A Protein (2009) (44)
Hepatitis C Virus nonstructural 5A protein inhibits lipopolysaccharide-mediated apoptosis of hepatocytes by decreasing expression of Toll-like receptor 4. (2011) (44)
Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon response. (2007) (43)
Norovirus Binding to Intestinal Epithelial Cells Is Independent of Histo-Blood Group Antigens (2013) (43)
Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection (2017) (42)
Hepatitis C virus NS2 protein triggers endoplasmic reticulum stress and suppresses its own viral replication. (2010) (42)
Asian Musk Shrew as a Reservoir of Rat Hepatitis E Virus, China (2013) (42)
Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide (2015) (42)
Adaptive mutations in the genomes of enterovirus 71 strains following infection of mouse cells expressing human P-selectin glycoprotein ligand-1 (2011) (42)
Tightly regulated expression of the entire hepatitis C virus structural region in continuous human cell lines. (1998) (40)
Japanese Reference Panel of Blood Specimens for Evaluation of Hepatitis C Virus RNA and Core Antigen Quantitative Assays (2012) (40)
Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus (2016) (40)
The Hepatitis E Virus Capsid C-Terminal Region Is Essential for the Viral Life Cycle: Implication for Viral Genome Encapsidation and Particle Stabilization (2013) (39)
Human induced-pluripotent stem cell-derived hepatocyte-like cells as an in vitro model of human hepatitis B virus infection (2017) (39)
Inoculation of Plasmids Encoding Japanese Encephalitis Virus PrM-E Proteins with Colloidal Gold Elicits a Protective Immune Response in BALB/c Mice (2003) (39)
Monitoring the Antiviral Effect of Alpha Interferon on Individual Cells (2007) (38)
Transmembrane serine protease TMPRSS2 activates hepatitis C virus infection (2015) (38)
Antimicrobial peptide LL‐37 attenuates infection of hepatitis C virus (2016) (38)
Effects of TJ-9 Sho-saiko-to (kampo medicine) on interferon gamma and antibody production specific for hepatitis B virus antigen in patients with type B chronic hepatitis. (1991) (38)
Establishment of an infectious genotype 1b hepatitis C virus clone in human hepatocyte chimeric mice. (2008) (37)
Hepatitis B Virus and Hepatitis D Virus Entry, Species Specificity, and Tissue Tropism. (2015) (37)
A Genome Epidemiological Study of SARS-CoV-2 Introduction into Japan (2020) (37)
The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network (2019) (37)
Possible role of cytotoxic T cells in acute liver injury in hepatitis C virus cDNA transgenic mice mediated by Cre/loxP system (2000) (37)
Binding activity of norovirus and sapovirus to histo-blood group antigens (2006) (36)
Absence of viral interference and different susceptibility to interferon between hepatitis B virus and hepatitis C virus in human hepatocyte chimeric mice. (2009) (36)
Descriptive study of COVID-19 outbreak among passengers and crew on Diamond Princess cruise ship, Yokohama Port, Japan, 20 January to 9 February 2020 (2020) (36)
Corrigendum: Production of infectious hepatitis C virus in tissue culture from a cloned viral genome (2005) (35)
Efficient production of type 2 porcine circovirus-like particles by a recombinant baculovirus (2008) (35)
A Disulfide-Bonded Dimer of the Core Protein of Hepatitis C Virus Is Important for Virus-Like Particle Production (2010) (35)
HCV NS3 protease enhances liver fibrosis via binding to and activating TGF-β type I receptor (2013) (35)
Comparison between cytomegalovirus promoter and elongation factor-1 alpha promoter-driven constructs in the establishment of cell lines expressing hepatitis C virus core protein. (1997) (35)
Processing of hepatitis C virus core protein is regulated by its C‐terminal sequence (2003) (35)
Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication (2017) (35)
Hepatitis C virus has a genetically determined lymphotropism through co-receptor B7.2 (2017) (34)
Induction of humoural and cellular immunity by immunisation with HCV particle vaccine in a non-human primate model (2016) (34)
Characterization of sapoviruses detected in gastroenteritis outbreaks and identification of asymptomatic adults with high viral load. (2009) (34)
High-throughput neutralization assay for multiple flaviviruses based on single-round infectious particles using dengue virus type 1 reporter replicon (2018) (34)
Effects of cyclosporin A on hepatitis C virus infection in bone marrow transplant patients (1997) (34)
Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes (2019) (33)
Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice (2003) (33)
Arsenic Trioxide Inhibits Hepatitis C Virus RNA Replication through Modulation of the Glutathione Redox System and Oxidative Stress (2008) (33)
Prominent Steatosis with Hypermetabolism of the Cell Line Permissive for Years of Infection with Hepatitis C Virus (2014) (33)
A confirmation of sapovirus re-infection gastroenteritis cases with different genogroups and genetic shifts in the evolving sapovirus genotypes, 2002-2011 (2012) (33)
Isolation of JFH-1 strain and development of an HCV infection system. (2009) (32)
Inhibitory Effects of Caffeic Acid, a Coffee-Related Organic Acid, on the Propagation of Hepatitis C Virus. (2015) (32)
Induction of hepatic injury by hepatitis C virus-specific CD8+ murine cytotoxic T lymphocytes in transgenic mice expressing the viral structural genes. (2003) (32)
Chronic Hepatitis B Prevalence among Children and Mothers: Results from a Nationwide, Population-Based Survey in Lao People's Democratic Republic (2014) (32)
Development of a Poliovirus Neutralization Test with Poliovirus Pseudovirus for Measurement of Neutralizing Antibody Titer in Human Serum (2011) (32)
Development of plaque assays for hepatitis C virus-JFH1 strain and isolation of mutants with enhanced cytopathogenicity and replication capacity. (2008) (32)
Inactivation of hepatitis A virus by heat and high hydrostatic pressure: variation among laboratory strains (2009) (31)
Production of single-round infectious chimeric flaviviruses with DNA-based Japanese encephalitis virus replicon. (2014) (31)
Report from a Viral Hepatitis Policy Forum on implementing the WHO Framework for Global Action on viral hepatitis in North Asia. (2013) (31)
Apoptosis in cultured rat hepatocytes: the effects of tumour necrosis factor alpha and interferon gamma. (1991) (31)
Pilot study of ribavirin and interferon‐β for chronic hepatitis B (1993) (31)
Quantitative analysis of fecal sapovirus shedding: identification of nucleotide substitutions in the capsid protein during prolonged excretion (2009) (30)
A national reference for inactivated polio vaccine derived from Sabin strains in Japan. (2014) (30)
Rosmarinic acid is a novel inhibitor for Hepatitis B virus replication targeting viral epsilon RNA-polymerase interaction (2018) (30)
Treatment with human gamma interferon of chronic hepatitis B: Comparative study with alpha interferon (1991) (30)
Cellular vimentin content regulates the protein level of hepatitis C virus core protein and the hepatitis C virus production in cultured cells. (2009) (30)
Molecular dissection of HBV evasion from restriction factor tetherin: A new perspective for antiviral cell therapy (2015) (30)
Characterization of miR-122-independent propagation of HCV (2017) (29)
Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Returnees to Japan from Wuhan, China, 2020 (2020) (29)
TT virus infection in hemodialysis patients (1999) (29)
Isolation and characterization of an Huh.7.5.1-derived cell clone highly permissive to hepatitis C virus. (2015) (29)
A cell-based, microplate colorimetric screen identifies 7,8-benzoflavone and green tea gallate catechins as inhibitors of the hepatitis C virus. (2012) (29)
The aryl hydrocarbon receptor–cytochrome P450 1A1 pathway controls lipid accumulation and enhances the permissiveness for hepatitis C virus assembly (2018) (28)
Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins. (2008) (28)
Griseofulvin, an oral antifungal agent, suppresses hepatitis C virus replication in vitro (2008) (28)
Toll-Like Receptor 2 Senses Hepatitis C Virus Core Protein but Not Infectious Viral Particles (2009) (28)
Comparison of envelope and precore/core variants of hepatitis B virus (HBV) during chronic HBV infection. (1993) (28)
Ferret hepatitis E virus infection induces acute hepatitis and persistent infection in ferrets. (2016) (28)
Antiviral effects of antisense RNA on hepatitis C virus RNA translation and expression (1999) (27)
Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha (2010) (27)
Environmental sampling for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during a coronavirus disease (COVID-19) outbreak aboard a commercial cruise ship (2020) (27)
Impaired antiviral activity of interferon alpha against hepatitis C virus 2a in Huh-7 cells with a defective Jak-Stat pathway (2010) (26)
Complete Genome Sequence of a Novel GV.2 Sapovirus Strain, NGY-1, Detected from a Suspected Foodborne Gastroenteritis Outbreak (2015) (26)
Development of a reverse transcription-loop-mediated isothermal amplification (RT-LAMP) system for a highly sensitive detection of enterovirus in the stool samples of acute flaccid paralysis cases (2009) (25)
Production of tumor necrosis factor, interleukin 1, and interferon-gamma by peripheral blood mononuclear cells from patients with primary biliary cirrhosis. (1990) (25)
Involvement of the 3’ Untranslated Region in Encapsidation of the Hepatitis C Virus (2016) (25)
Hepatitis A outbreak associated with a revolving sushi bar in Chiba, Japan: Application of molecular epidemiology (2012) (25)
Targeting Cellular Squalene Synthase, an Enzyme Essential for Cholesterol Biosynthesis, Is a Potential Antiviral Strategy against Hepatitis C Virus (2014) (25)
Effects of Resistance-Associated NS5A Mutations in Hepatitis C Virus on Viral Production and Susceptibility to Antiviral Reagents (2016) (25)
Specific inhibition of hepatitis C virus entry into host hepatocytes by fungi-derived sulochrin and its derivatives. (2013) (24)
Trans-complemented hepatitis C virus particles as a versatile tool for study of virus assembly and infection. (2012) (24)
Scavenger Receptor BI Is a Key Host Factor for Hepatitis C Virus Infection Required for an Entry Step Closely Linked to CD 81 (2009) (24)
New immunoassays for total, IgA and IgM antibodies against hepatitis E virus: Prevalence in Italian blood donors and patients with chronic liver or kidney diseases. (2016) (24)
An infectious and selectable full‐length replicon system with hepatitis C virus JFH‐1 strain (2007) (24)
Cell culture and in vivo analyses of cytopathic hepatitis C virus mutants. (2010) (24)
A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction. (2018) (23)
Development of Mouse Hepatocyte Lines Permissive for Hepatitis C Virus (HCV) (2011) (23)
Serial analysis of hepatitis B virus core nucleotide sequence of patients with acute exacerbation during chronic infection (1996) (23)
Peroxiredoxin 1, a Novel HBx-Interacting Protein, Interacts with Exosome Component 5 and Negatively Regulates Hepatitis B Virus (HBV) Propagation through Degradation of HBV RNA (2018) (23)
Hepatitis B virus X protein impairs α‐interferon signaling via up‐regulation of suppressor of cytokine signaling 3 and protein phosphatase 2A (2017) (23)
Prevalence of SARS-CoV-2–Specific Antibodies, Japan, June 2020 (2021) (23)
Characterization of porcine sapelovirus isolated from Japanese swine with PLC/PRF/5 cells (2018) (23)
Structural requirements of virion-associated cholesterol for infectivity, buoyant density and apolipoprotein association of hepatitis C virus. (2011) (23)
Molecular characterization of sapovirus detected in a gastroenteritis outbreak at a wedding hall (2010) (23)
In vivo adaptation of hepatitis C virus in chimpanzees for efficient virus production and evasion of apoptosis (2011) (22)
Hepatitis C Virus Nonstructural 5 A Protein Inhibits Lipopolysaccharide-Mediated Apoptosis of Hepatocytes by Decreasing Expression of Toll-Like Receptor 4 (2011) (22)
RNA Exosome Complex Regulates Stability of the Hepatitis B Virus X-mRNA Transcript in a Non-stop-mediated (NSD) RNA Quality Control Mechanism* (2016) (22)
Epidemiological and genetic analysis of a 2014 outbreak of hepatitis A in Japan. (2015) (22)
E6AP ubiquitin ligase mediates ubiquitin‐dependent degradation of peroxiredoxin 1 (2010) (22)
Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study (2021) (22)
Double-stranded RNA-induced interferon-beta and inflammatory cytokine production modulated by hepatitis C virus serine proteases derived from patients with hepatic diseases (2009) (22)
Epidemiological and genetic analyses of a diffuse outbreak of hepatitis A in Japan, 2010. (2012) (22)
Replication and infectivity of a novel genotype 1b hepatitis C virus clone (2012) (21)
Effects of various cytokines on collagen synthesis by normal rat hepatocytes in primary cultures and fibroblasts. (1989) (21)
Suppression of La Antigen Exerts Potential Antiviral Effects against Hepatitis A Virus (2014) (21)
CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c‐jun N terminal kinase activation independent from the interferon pathway (2013) (20)
Identification of bisindolylmaleimides and indolocarbazoles as inhibitors of HCV replication by tube-capture-RT-PCR. (2009) (20)
Production and characterization of HCV particles from serum-free culture. (2011) (20)
Epidemiological and genetic analyses of a diffuse outbreak of hepatitis A in Japan, 2010. (2012) (20)
Concept of Viral Inhibitors via NTCP (2019) (20)
Evaluation of Heating Conditions for Inactivation of Hepatitis E Virus Genotypes 3 and 4. (2018) (20)
Alternative endocytosis pathway for productive entry of hepatitis C virus. (2014) (20)
Monoclonal Antibodies against Occludin Completely Prevented Hepatitis C Virus Infection in a Mouse Model (2018) (20)
Characterization of self-assembled virus-like particles of ferret hepatitis E virus generated by recombinant baculoviruses. (2013) (20)
Involvement of PUF60 in Transcriptional and Post-transcriptional Regulation of Hepatitis B Virus Pregenomic RNA Expression (2017) (19)
Interleukin-29 suppresses hepatitis A and C viral internal ribosomal entry site-mediated translation. (2012) (19)
Virological characterization of the hepatitis C virus JFH-1 strain in lymphocytic cell lines. (2008) (19)
An interferon-like small chemical compound CDM-3008 suppresses hepatitis B virus through induction of interferon-stimulated genes (2019) (19)
Acidic polysaccharides isolated from marine algae inhibit the early step of viral infection. (2019) (19)
Fatty acid biosynthesis is involved in the production of hepatitis B virus particles. (2016) (19)
Immunization with a Recombinant Vaccinia Virus That Encodes Nonstructural Proteins of the Hepatitis C Virus Suppresses Viral Protein Levels in Mouse Liver (2012) (19)
Epidemiology of domestically acquired hepatitis E virus infection in Japan: assessment of the nationally reported surveillance data, 2007-2013. (2015) (18)
Characterization of self-assembled virus-like particles of dromedary camel hepatitis e virus generated by recombinant baculoviruses (2015) (18)
Cyclophilin inhibitors reduce phosphorylation of RNA-dependent protein kinase to restore expression of IFN-stimulated genes in HCV-infected cells. (2014) (18)
Candidatus Mycoplasma haemohominis in Human, Japan (2020) (18)
Revisiting the guidelines for ending isolation for COVID-19 patients (2021) (18)
Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System (2016) (18)
Structural and biological constraints on diversity of regions immediately upstream of cleavage sites in calicivirus precursor proteins. (2009) (18)
Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide (2018) (18)
Interleukin 6 production by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection and primary biliary cirrhosis (1993) (18)
Occludin-Knockout Human Hepatic Huh7.5.1-8-Derived Cells Are Completely Resistant to Hepatitis C Virus Infection. (2016) (18)
Effect of sizofiran, a polysaccharide, on interferon gamma, antibody production and lymphocyte proliferation specific for hepatitis B virus antigen in patients with chronic hepatitis B. (1991) (18)
Inhibition of preS1-hepatocyte interaction by an array of recombinant human antibodies from naturally recovered individuals (2016) (18)
Characterization of Self-Assembled Virus-Like Particles of Merkel Cell Polyomavirus (2015) (18)
Modification of hepatitis C virus 1b RNA polymerase to make a highly active JFH1-type polymerase by mutation of the thumb domain (2009) (18)
Prolactin Regulatory Element Binding Protein Is Involved in Hepatitis C Virus Replication by Interaction with NS4B (2016) (17)
Nanoimaging of ssRNA: Genome Architecture of the Hepatitis C Virus Revealed by Atomic Force Microscopy (2011) (17)
Seroprevalence of trichodysplasia spinulosa-associated polyomavirus in Japan. (2015) (17)
Seroprevalence of chronic hepatitis B, as determined from dried blood spots, among children and their mothers in central Lao People's Democratic Republic: a multistage, stratified cluster sampling survey. (2015) (17)
Cellular immune responses of peripheral blood mononuclear cells to HBV antigens during chronic and acute HBV infection. (1992) (17)
The prevalence of TT virus (TTV) infection and its relationship to hepatitis in children (1999) (17)
Serological evidence of hepatitis E virus infection in dromedary camels in Ethiopia. (2017) (16)
A Single Adaptive Mutation in Sodium Taurocholate Cotransporting Polypeptide Induced by Hepadnaviruses Determines Virus Species Specificity (2018) (16)
Distinct genotype and antigenicity among genogroup II sapoviruses (2009) (16)
Generation of hepatitis E virus-like particles of two new genotypes G5 and G6 and comparison of antigenic properties with those of known genotypes. (2015) (16)
Possible widespread presence of hepatitis A virus subgenotype IIIA in Japan: Recent trend of hepatitis A causing acute liver failure (2012) (16)
Saturation Mutagenesis reveals that GLU54 of Norovirus 3C-like Protease is not Essential for the Proteolytic Activity (2008) (16)
Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro (2021) (16)
Seroepidemiological study of hepatitis B virus markers in Japan. (2015) (15)
Production of infectious ferret hepatitis E virus in a human hepatocarcinoma cell line PLC/PRF/5. (2016) (15)
Resistance mutations of hepatitis B virus in entecavir‐refractory patients (2017) (15)
Structural insights into the HBV receptor and bile acid transporter NTCP (2022) (15)
Cell culture-adaptive mutations in the NS5B gene of hepatitis C virus with delayed replication and reduced cytotoxicity. (2009) (15)
MicroRNA-27a Modulates HCV Infection in Differentiated Hepatocyte-Like Cells from Adipose Tissue-Derived Mesenchymal Stem Cells (2014) (15)
Completion of the Entire Hepatitis C Virus Life Cycle in Vero Cells Derived from Monkey Kidney (2016) (15)
Integrin α3 is involved in non-enveloped hepatitis E virus infection. (2019) (15)
Galectin-9 restricts hepatitis B virus replication via p62/SQSTM1-mediated selective autophagy of viral core proteins (2022) (15)
Expression of human factors CD81, claudin-1, scavenger receptor, and occludin in mouse hepatocytes does not confer susceptibility to HCV entry. (2011) (15)
Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro (2021) (15)
[Production of infectious hepatitis C virus in cell culture]. (2005) (15)
Anti-hepatitis C antibodies in patients with chronic non-A, non-B hepatitis: relation to disease progression and effect of interferon alpha. (1991) (15)
Interferon-gamma production specific for hepatitis B virus antigen by intrahepatic T lymphocytes in patients with acute and chronic hepatitis B. (1994) (15)
Sphingomyelin Is Essential for the Structure and Function of the Double-Membrane Vesicles in Hepatitis C Virus RNA Replication Factories (2020) (15)
Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide (2018) (15)
Molecular detection of hepatitis E virus in rivers in the Philippines. (2014) (14)
Establishment of hepatitis E virus infection‐permissive and ‐non‐permissive human hepatoma PLC/PRF/5 subclones (2015) (14)
Evaluation of Hepatitis C Virus Core Antigen Assays in Detecting Recombinant Viral Antigens of Various Genotypes (2009) (14)
COVID-19 genome surveillance at international airport quarantine stations in Japan (2020) (14)
Chronic Hepatitis E Infection in a Persistently Immunosuppressed Patient Unable to Be Eliminated after Ribavirin Therapy (2016) (14)
Production of Infectious Chimeric Hepatitis C Virus Genotype 2b Harboring Minimal Regions of JFH-1 (2011) (13)
A Subclone of HuH-7 with Enhanced Intracellular Hepatitis C Virus Production and Evasion of Virus Related-Cell Cycle Arrest (2012) (13)
Host factor PRPF31 is involved in cccDNA production in HBV-replicating cells. (2017) (13)
PML tumor suppressor protein is required for HCV production. (2013) (13)
Identification of Antiviral Agents Targeting Hepatitis B Virus Promoter from Extracts of Indonesian Marine Organisms by a Novel Cell-Based Screening Assay (2015) (13)
Bioluminescence technologies to detect calicivirus protease activity in cell-free system and in infected cells (2011) (13)
Hepatitis C Virus Nonstructural Protein 5A Inhibits Thapsigargin-Induced Apoptosis (2014) (13)
Hepatitis C virus-induced innate immune responses in human iPS cell-derived hepatocyte-like cells. (2017) (12)
An in‐house‐anti‐hepatitis A virus (HAV)‐specific immunoglobulin M capture enzyme‐linked immunosorbent assay: Evaluation and application to an HAV outbreak (2009) (12)
Potent and selective inhibition of hepatitis C virus replication by novel phenanthridinone derivatives. (2011) (12)
Single-domain intrabodies against hepatitis C virus core inhibit viral propagation and core-induced NFκB activation. (2016) (12)
Biological properties of purified recombinant HCV particles with an epitope-tagged envelope. (2010) (12)
Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C (2015) (12)
Small Animal Models of Hepatitis E Virus Infection. (2019) (12)
The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathione (2022) (12)
Hepatitis C virus NS4B targets lipid droplets through hydrophobic residues in the amphipathic helices[S] (2013) (12)
Raloxifene inhibits hepatitis C virus infection and replication (2012) (12)
Dual Agonist of Farnesoid X Receptor and Takeda G Protein‐Coupled Receptor 5 Inhibits Hepatitis B Virus Infection In Vitro and In Vivo (2021) (12)
Structural Basis for Specific Recognition of Substrates by Sapovirus Protease (2012) (11)
Development of hepatitis C virus production reporter-assay systems using two different hepatoma cell lines. (2012) (11)
N‐Terminal PreS1 Sequence Regulates Efficient Infection of Cell‐Culture–Generated Hepatitis B Virus (2020) (11)
Current status of hepatitis E virus infection at a rhesus monkey farm in China. (2019) (11)
Annexin A1 negatively regulates viral RNA replication of hepatitis C virus. (2015) (11)
A class II phosphoinositide 3-kinase plays an indispensable role in hepatitis C virus replication. (2013) (11)
La protein required for internal ribosome entry site-directed translation is a potential therapeutic target for hepatitis C virus replication. (2010) (11)
Characterization of anti-idiotypic antibodies mimicking antibody- and receptor-binding sites on hepatitis A virus (2009) (11)
Hepatitis C virus RNA replication in human stellate cells regulates gene expression of extracellular matrix-related molecules. (2011) (11)
Different mechanisms of hepatitis C virus RNA polymerase activation by cyclophilin A and B in vitro. (2012) (11)
Development of recombinant hepatitis C virus with NS5A from strains of genotypes 1 and 2. (2011) (10)
Evaluation of in vitro screening and diagnostic kits for hepatitis B virus infection. (2019) (10)
Development of an Infectious HCV Cell Culture System (2006) (10)
Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly. (2019) (10)
Retrotransposon elements among initial sites of hepatitis B virus integration into human genome in the HepG2-NTCP cell infection model. (2019) (10)
Engineering Cellular Biosensors with Customizable Antiviral Responses Targeting Hepatitis B Virus (2020) (10)
SARS-CoV-2 Screening Test for Japanese Returnees From Wuhan, China, January 2020 (2020) (10)
Evaluation of in vitro screening and diagnostic kits for hepatitis C virus infection. (2018) (10)
HCV genotype 1b chimeric replicon with NS5B of JFH-1 exhibited resistance to cyclosporine A (2009) (10)
Surfeit 4 Contributes to the Replication of Hepatitis C Virus Using Double-Membrane Vesicles (2019) (10)
Serologic testing of randomly selected children after hepatitis B vaccination: a cross-sectional population-based study in Lao People’s Democratic Republic (2019) (9)
Self‐assembly of sapovirus recombinant virus‐like particles from polyprotein in mammalian cells (2009) (9)
Inhibition Mechanisms of Hepatitis C Virus Infection by Caffeic Acid and Tannic Acid. (2019) (9)
Characterization of infectious hepatitis C virus from liver-derived cell lines. (2008) (9)
Pilot study of ribavirin and interferon-beta for chronic hepatitis B. (1993) (9)
A retrospective study on imported hepatitis E in Japan. (2012) (9)
ULBP1 is induced by hepatitis C virus infection and is the target of the NK cell‐mediated innate immune response in human hepatocytes (2018) (9)
Bardoxolone methyl as a novel potent antiviral agent against hepatitis B and C viruses in human hepatocyte cell culture systems. (2019) (9)
Novel Permissive Cell Lines for Complete Propagation of Hepatitis C Virus (2014) (9)
Cell Culture Systems of HCV Using JFH-1 and Other Strains. (2019) (9)
Comparative site‐directed mutagenesis in the catalytic amino acid triad in calicivirus proteases (2011) (9)
Detection of Multiple Human Sapoviruses from Imported Frozen Individual Clams (2013) (9)
Clinical Features and Transmission Pattern of Hepatitis A: An Experience from a Hepatitis A Outbreak Caused by Two Cocirculating Genotypes in Sri Lanka. (2016) (9)
IL-1β/ATF3-mediated induction of Ski2 expression enhances hepatitis B virus x mRNA degradation. (2018) (9)
Rethinking antiviral effects for COVID-19 in clinical studies: early initiation is key to successful treatment (2020) (9)
Comparisons of peripheral blood and hepatic lymphocyte subpopulations and interferon production in chronic viral hepatitis. (1990) (9)
Identification of hepatitis C virus genotype 2a replicon variants with reduced susceptibility to ribavirin. (2010) (9)
In vitro production of antibody to hepatitis B core and E antigens by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection. (1990) (8)
Comparative characterization of flavivirus production in two cell lines: Human hepatoma-derived Huh7.5.1-8 and African green monkey kidney-derived Vero (2020) (8)
Genetic and physicochemical analyses of a novel ferret hepatitis E virus, and clinical signs of infection after birth. (2017) (8)
Vitamin D derivatives inhibit hepatitis C virus production through the suppression of apolipoprotein (2018) (8)
Prolyl Isomerase Pin1 Regulates the Stability of Hepatitis B Virus Core Protein (2020) (8)
Activation of protein kinase R by hepatitis C virus RNA-dependent RNA polymerase. (2019) (8)
Development of a Transcription-Reverse Transcription Concerted Reaction Method for Specific Detection of Human Enterovirus 71 from Clinical Specimens (2012) (8)
Corrigendum to: Hepatitis C virus NS2 protein triggers endoplasmic reticulum stress and suppresses its own viral replication [J Hepatol. 2010 Nov;53(5):797–804] (2011) (8)
Effects of transforming growth factor‐β1 against the inhibitory action of interferon on DNA synthesis and viral replication in hepatitis B virus DNA‐transfected cell (1992) (7)
Hepatitis B virus prevents excessive viral production via reduction of cell death-inducing DFF45-like effectors. (2017) (7)
Identification of Two Critical Neutralizing Epitopes in the Receptor Binding Domain of Hepatitis B Virus preS1 (2020) (7)
HCV research and anti-HCV drug discovery: toward the next generation. (2007) (7)
Single Strain Isolation Method for Cell Culture-Adapted Hepatitis C Virus by End-Point Dilution and Infection (2014) (7)
Erratum: Production of infectious hepatitis C virus in tissue culture from a cloned viral genome (Nature Medicine (2005) 11 (791-796)) (2005) (7)
Establishment of a novel hepatitis B virus culture system using immortalized human hepatocytes (2020) (7)
Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression (2015) (7)
New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication (2013) (7)
Inhibitory effect of fasiglifam on hepatitis B virus infections through suppression of the sodium taurocholate cotransporting polypeptide. (2018) (7)
Rab13 Is Involved in the Entry Step of Hepatitis C Virus Infection. (2016) (7)
Suppression of hepatitis C virus replication by cyclin-dependent kinase inhibitors. (2014) (7)
Development of a Particle Agglutination Method with Soluble Virus Receptor for Identification of Poliovirus (2010) (6)
Non-nucleoside hepatitis B virus polymerase inhibitors identified by an in vitro polymerase elongation assay (2019) (6)
Baculovirus Mediated Production of Infectious Hepatitis C Virus in Human Hepatoma Cells Stably Expressing T7 RNA Polymerase (2008) (6)
Time variation in the probability of failing to detect a case of polymerase chain reaction testing for SARS-CoV-2 as estimated from a viral dynamics model (2021) (6)
Reply to Padmanabhan and Dixit: Hepatitis C virus entry inhibitors for optimally boosting direct-acting antiviral-based treatments (2017) (6)
Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production (2016) (6)
Anti‐ulcer agent teprenone inhibits hepatitis C virus replication: potential treatment for hepatitis C (2011) (6)
Screening for inhibitor of episomal DNA identified dicumarol as a hepatitis B virus inhibitor (2019) (6)
Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus (2016) (6)
Acute hepatitis B of genotype H resulting in persistent infection. (2014) (6)
Gamma-interferon production in response to hepatitis B core protein and its synthetic peptides in patients with chronic hepatitis B virus infection. (1990) (6)
Interferon signaling suppresses the unfolded protein response and induces cell death in hepatocytes accumulating hepatitis B surface antigen (2020) (6)
miR-27b-mediated suppression of aquaporin-11 expression in hepatocytes reduces HCV genomic RNA levels but not viral titers (2019) (6)
Generation of a recombinant reporter hepatitis C virus useful for the analyses of virus entry, intra-cellular replication and virion production. (2012) (5)
Interleukin-1 and tumor necrosis factor-α trigger restriction of hepatitis B virus infection via a cytidine deaminase AID (2013) (5)
Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial (2021) (5)
Hepatitis C Virus Nonstructural Protein 5A Inhibits MG132-Induced Apoptosis of Hepatocytes in Line with NF-κB-Nuclear Translocation (2015) (5)
Genotype distribution in Nagoya and new genotype (genotype 3a) in Japanese patients with hepatitis C virus (1995) (5)
[Hepatitis C virus vaccine]. (2008) (5)
Establishment of a human hepatocellular cell line capable of maintaining long-term replication of hepatitis B virus (2017) (5)
Human-rat chimeric anti-occludin monoclonal antibodies inhibit hepatitis C virus infection. (2019) (4)
Studies on virus kinetics using infectious fluorescence‐tagged hepatitis C virus cell culture (2011) (4)
NTCP Oligomerization Occurs Downstream of the NTCP-EGFR Interaction during Hepatitis B Virus Internalization (2021) (4)
[Defective short variants of S region in chronic HBV carriers]. (1993) (4)
Screening siRNAs against host glycosylation pathways to develop novel antiviral agents against hepatitis B virus (2020) (4)
O.174 Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus (2006) (4)
Oncogenic transcriptomic profile is sustained in the liver after the eradication of the hepatitis C virus. (2021) (4)
Prevalence of equine hepacivirus infection in Mongolia. (2020) (4)
Detection of Subgenotype IA and IIIA Hepatitis A Viruses in Rivers Flowing through Metro Manila, the Philippines. (2019) (4)
Determination of Ferret Enteric Coronavirus Genome in Laboratory Ferrets (2017) (4)
Thermostable hepatitis C virus JFH1-derived variant isolated by adaptation to Huh7.5.1 cells. (2018) (4)
Hepatitis C Virus-Induced Degradation of Cell Death-Inducing DFFA-Like Effector B Leads to Hepatic Lipid Dysregulation (2016) (4)
Thromboxane A2 synthase inhibitors prevent production of infectious hepatitis C virus in mice with humanized livers. (2013) (4)
Genotype 2 a Hepatitis C Virus Subgenomic Replicon Can Replicate in HepG 2 and IMY-N 9 cells (2004) (4)
Should a viral genome stay in the host cell or leave? A quantitative dynamics study of how hepatitis C virus deals with this dilemma (2020) (4)
The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses (2020) (4)
No Evidence of Rat Hepatitis E Virus Excretion in Urine Samples of Rats. (2017) (4)
Detergent-induced activation of the hepatitis C virus genotype 1b RNA polymerase. (2012) (4)
Interferon sensitivity-determining region of hepatitis C virus influences virus production and interferon signaling (2015) (3)
Development of hepatoma-derived, bidirectional oval-like cells as a model to study host interactions with hepatitis C virus during differentiation. (2017) (3)
Isolation and characterization of hepatitis C virus resistant to a novel phenanthridinone derivative (2015) (3)
Biochemical and Structural Properties of Entecavir-Resistant Hepatitis B Virus Polymerase with L180M/M204V Mutations (2021) (3)
Epidemiological assessment of interventions to eliminate mother‐to‐child transmission of hepatitis B virus in japan (2020) (3)
Development of hepatoma-derived, bidirectional oval-like cells as a model to study host interactions with hepatitis C virus during differentiation (2017) (3)
Corrigendum to: Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship (2020) (3)
Characterization of human bocavirus-like particles generated by recombinant baculoviruses. (2014) (3)
10 CYCLOPHILIN INHIBITORS POTENTIATE INTERFERON SIGNALING THROUGH DIMINISHED PKR PHOSPHORYLATION IN HCV-INFECTED CELLS (2013) (3)
Immune response of peripheral blood mononuclear cells to antigenic determinants within hepatitis B core antigen in HB virus-infected man. (2008) (3)
Effect of recombinant human transforming growth factor β1 on immune responses in patients with chronic hepatitis B (2008) (3)
Hepatitis C Virus-Induced ROS/JNK Signaling Pathway Activates the E3 Ubiquitin Ligase Itch to Promote the Release of HCV Particles via Polyubiquitylation of VPS4A (2022) (3)
Cytotoxic T lymphocyte activity to hepatitis B virus DNA-transfected HepG2 cells in patients with chronic hepatitis B (1993) (3)
Effect of recombinant human transforming growth factor beta 1 on immune responses in patients with chronic hepatitis B. (1993) (3)
CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection (2014) (2)
The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro (2022) (2)
Hepatitis B virus prevents excessive viral production via reduction of cell death-inducing DFF 45-like effectors (2017) (2)
Virus-like particles of porcine bocavirus generated by recombinant baculoviruses can be applied to sero-epidemic studies. (2016) (2)
Structural Analysis of Long Single-Stranded RNA Molecules with Atomic Force Microscopy Imaging (2017) (2)
Caffeic acid , a coffee-related organic acid , inhibits the propagation of hepatitis C virus (2014) (2)
Hepatitis C Virus II (2016) (2)
National seroepidemiological study of COVID‐19 after the initial rollout of vaccines: Before and at the peak of the Omicron‐dominant period in Japan (2023) (2)
MafF Is an Antiviral Host Factor That Suppresses Transcription from Hepatitis B Virus Core Promoter (2021) (2)
Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based Therapy (2017) (2)
Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/ Ribavirin Therapy in Chronic Hepatitis C (2015) (2)
Induction of neutralizing antibodies against hepatitis C virus by a subviral particle-based DNA vaccine. (2022) (2)
Occludin‐binding single‐chain variable fragment and antigen‐binding fragment antibodies prevent hepatitis C virus infection (2020) (2)
Differences in hepatitis C virus core protein processing among genotypes 1 and 2. (2004) (2)
Will there be an HCV meeting in 2020? Summary of the 17th international meeting on hepatitis C virus and related viruses. (2011) (2)
Development of an intervention system for linkage-to-care and follow-up for hepatitis B and C virus carriers (2021) (2)
The kinesin KIF4 mediates HBV/HDV entry through regulation of surface NTCP localization and can be targeted by RXR agonists in vitro (2021) (2)
A Single Adaptive Mutation in Sodium Taurocholate Cotransporting Polypeptide Induced by Hepadnaviruses Determines Virus Species-specificity (2018) (2)
Retinoids and rexinoids inhibit hepatitis C virus independently of retinoid receptor signaling. (2014) (2)
Establishment of infectious genotype 4 cell culture-derived hepatitis C virus. (2019) (2)
665 CULTURE OF HEPATITIS C VIRUS (HCV) IN PRIMARY HUMAN ADULT HEPATOCYTES: A PHYSIOLOGICAL MODEL FOR THE PRODUCTION OF AUTHENTIC INFECTIOUS PARTICLES (2010) (2)
Antiviral Effects of the Anti-Occludin Monoclonal Antibody on Persistent Hepatitis C Virus Infection in a Human Liver Chimeric Mouse Model (2021) (2)
Identification of natural compounds extracted from crude drugs as novel inhibitors of hepatitis C virus. (2021) (2)
Ledipasvir and Sofosbuvir for Acute Hepatitis C Virus Monoinfection Associated with a High Risk of Acute Liver Failure (2019) (2)
T cell lines reactive with hepatitis B core and E antigens in patients with chronic hepatitis B. (1991) (1)
Evaluation of antiviral effects of novel NS5A inhibitors in hepatitis C virus cell culture system with full‐genome infectious clones (2018) (1)
Establishment of Replication-Competent HCV Strain with Minimum Modifications. (2018) (1)
encapsidation and particle stabilization (2013) (1)
Required concentration index quantifies effective drug combinations against hepatitis C virus infection (2020) (1)
Novel stable HBV producing cell line systems for expression and screening antiviral inhibitor of hepatitis B virus in human hepatoma cell line. (2018) (1)
Corrigendum: Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression (2015) (1)
Correction: New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication (2013) (1)
Proactive Engagement of the Expert Meeting in Managing the Early Phase of the COVID-19 Epidemic, Japan, February–June 2020 (2021) (1)
P-45 Development and immune response to HCV-core DNA vaccine constructs (1995) (1)
MafF is an anti-viral host factor that suppresses transcription from Hepatitis B Virus and Epstein Barr Virus promoters (2020) (1)
Pol I-transcribed hepatitis C virus genome RNA replicates, produces an infectious virus and leads to severe hepatic steatosis in transgenic mice. (2015) (1)
Annexin A 1 Negatively Regulates Viral RNA Replication of Hepatitis C Virus (2015) (1)
Evaluation of the use of various rat strains for immunogenic potency tests of Sabin-derived inactivated polio vaccines. (2018) (1)
[The prevalence of TTV infection and the route of TTV transmission in hemodialysis patients--compared with HCV infection]. (1999) (1)
Call for papers for the renewed Microbiology and Immunology (2008) (1)
Hepatitis C virus inhibitor synergism suggests multistep interactions between heat-shock protein 90 and hepatitis C virus replication. (2016) (1)
Inhibition of hepatitis C virus antigen expression by antisense oligonucleotides directed against 5$prime; noncoding region ribosomal binding sites (1993) (1)
Neutralization assays for echovirus 18 isolates in 2006. (2007) (1)
Epigenetic reprogramming promotes the antiviral action of IFNα in HBV-infected cells (2021) (1)
A novel virus culture system for hepatitis C virus (2006) (1)
Amino Acid Polymorphism in Hepatitis B Virus Associated With Functional Cure (2021) (1)
Hepatitis B Virus Genotype-Dependent Vulnerability of Infected Cells to Immune Reaction in the Early Phase of Infection (2019) (1)
Anti-severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) potency of Mefloquine as an entry inhibitor in vitro (2020) (1)
Direct Inhibition of SARS-CoV-2 Spike Protein by Peracetic Acid (2022) (1)
Identification of Anti-COVID-19 Agents, Cepharanthine and Nelfinavir, and Their Potential Usage for Combination Treatment (2020) (1)
HCV Culture System and Antiviral Development (2008) (0)
How do we fight against novel coronaviruses : Japan's strategy with the members of the Council of Experts (2020) (0)
NSD degrades HBV X-mRNA at the SKIV2L/RNA exosome complex RNA exosome complex regulates stability of Hepatitis B Virus’s X-mRNA transcript in a Non-Stop mediated (NSD) RNA quality control mechanism. (2016) (0)
Creation of a mouse monoclonal antibody against HCV-E1 protein based on wheat cell-free technology. (2016) (0)
A confirmation of sapovirus re-infection gastroenteritis cases with different genogroups and genetic shifts in the evolving sapovirus genotypes, 2002-2011 (2012) (0)
Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide (2018) (0)
Crystal structure of P domain Q389N mutant from Norovirus Funabashi258 stain in the complex with Lewis-b (2012) (0)
Structural insights into the HBV receptor and bile acid transporter NTCP (2022) (0)
Identification and functional analysis of novel E3 ligases interacting with HCV NS4B. (2016) (0)
O.191 Production of infectious hepatitis C virus in cultured cells (2006) (0)
Crystal structure of P domain from Norovirus Funabashi258 stain in the complex with A-antigen (2012) (0)
Patient-derived monoclonal antibody neutralizes HCV infection in vitro and vivo without generating escape mutants (2022) (0)
Development and Use of a Kinetical and Real-Time Monitoring System to Analyze the Replication of Hepatitis C Virus (2022) (0)
Expression and immune response to hepatitis C virus DNA vaccine constructs (1995) (0)
Identification of neutralizing epitopes in the preS2 domain of the hepatitis B virus. (2023) (0)
Maturation and biological importance of hepatitic C virus core protein (1995) (0)
Notice of triplicate publication. (1990) (0)
Norovirus Classification, Where are We Headed? (2011) (0)
[Hepatitis virus culture and anti-viral development]. (2015) (0)
Specific inhibition of hepatitis C virus core antigen production by antisene RNA constructions (1995) (0)
A case of acute liver failure with echovirus infection diagnosed by a multi-virus real-time PCR system (2021) (0)
High-throughput neutralization assay for multiple flaviviruses based on single-round infectious particles using dengue virus type 1 reporter replicon (2018) (0)
Prediction of elimination of intrahepatic cccDNA in hepatitis B virus-infected patients by a combination of noninvasive viral markers (2022) (0)
Crystal structure of P domain from Norovirus Funabashi258 stain in the complex with Lewis-a (2012) (0)
Novel Neplanocin A Derivatives as Selective Inhibitors of Hepatitis B Virus with a Unique Mechanism of Action (2022) (0)
Novel HCV cell culture system using a genotype 2 strain with minimum modifications (2017) (0)
Cytotoxic T lymphocyte activity and HB virus mutant in chronic HB virus carriers (1993) (0)
Cooperation Between Japan’s NIID and China CDC in Japan’s COVID-19 Response (2020) (0)
Parallel Session Epidemiology VI QUANTIFYING ANTIVIRAL ACTIVITY OPTIMIZES DRUG COMBINATIONS AGAINST HEPATITIS C VIRUS INFECTION (2018) (0)
Reduced Resistance of SARS-CoV-2 Variants Toward Affinity-Matured Serological Immunity (2021) (0)
System for the production of infectious hepatitis C (2006) (0)
Epigenetic reprogramming promotes the antiviral action of IFNα in HBV-infected cells (2021) (0)
Required concentration index quantifies effective drug combinations against hepatitis C virus infection (2021) (0)
Hepatitis C Virus Infection Sensitizes Human Hepatocytes to TRAIL-Induced Apoptosis in a Caspase 9-Dependent Manner 1 (2008) (0)
[Hepatitis C virus culture and its application]. (2011) (0)
Independent evolution of multi-dominant viral genome species observed in a hepatitis C virus carrier (2022) (0)
Particle agglutination method for poliovirus identification. (2011) (0)
Corrigendum to: “Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia” [J Hepatol 2013;59:1073–1080] (2014) (0)
Inoculation of Plasmids Encoding Japanese Encephalitis Virus PrM-E Proteins with Colloidal Gold Elicits a Protective Immune Response in BALB/c Mice (2003) (0)
57: Pivotal role of the IKK-related kinase IKK epsilon to modulate IL29 or type I IFN induction during hepatitis C virus infection (2013) (0)
Erratum to: A confirmation of sapovirus re-infection gastroenteritis cases with different genogroups and genetic shifts in the evolving sapovirus genotypes, 2002-2011 (2013) (0)
Genome-wide CRISPR screen for HSV-1 host factors reveals PAPSS1 contributes to heparan sulfate synthesis (2022) (0)
Title: Novel Cell Culture-Adapted Genotype 2a Hepatitis C Virus Infectious Clone 1 2 (2012) (0)
[Critical roles of lipids in the HCV life cycle]. (2011) (0)
Identification of microRNA associated with the elimination of hepatitis C virus genotype 1b by direct‐acting antiviral therapies (2020) (0)
SEB genotyping: SmartAmp-Eprimer binary code genotyping for complex, highly variable targets applied to HBV (2022) (0)
Development of an HCV Cell Culture System (2012) (0)
Absence of viral interference and different susceptibility to interferon between Hepatitis B and C virus in human hepatocyte chimeric mice (2010) (0)
Author response: Revisiting the guidelines for ending isolation for COVID-19 patients (2021) (0)
XVIII. A Scientific Expert Advisory Board for the Infectious Disease Criisis (2020) (0)
Antipoliovirus Activity Target of Enviroxime-Like Compounds for Phosphatidylinositol 4-Kinase III Beta Is a (2013) (0)
Cell Culture Systems for Propagation of HCV (2016) (0)
Caspase 9-Dependent Manner Hepatocytes to TRAIL-Induced Apoptosis in a Hepatitis C Virus Infection Sensitizes Human (2011) (0)
(AID) Activation-induced Cytidine Deaminase Infection via a Cytidine Deaminase Trigger Restriction of Hepatitis B Virus ! Interleukin-1 and Tumor Necrosis Factor- Microbiology: (2014) (0)
589 HEPATITIS C VIRUS REPLICATION SENSITIZES HUMAN HEPATOMA CELLS TO TRAIL-INDUCED APOPTOSIS (2008) (0)
Characterization of Structural Elements in the HCV Genome using Atomic Force Microscopy (2019) (0)
Erratum to: A confirmation of sapovirus re-infection gastroenteritis cases with different genogroups and genetic shifts in the evolving sapovirus genotypes, 2002-2011 (2013) (0)
Identification and characterization of human monoclonal anti-E2 antibodies cloned from chronic hepatitis C patient (2016) (0)
A single mutation in the E2 glycoprotein of hepatitis C virus broadens the claudin specificity for its infection (2022) (0)
Detection of Multiple Human Sapoviruses from Imported Frozen Individual Clams (2013) (0)
[Comparison of the HBV-DNA sequences from a chronic hepatitis B patient and her children in cases of vertical transmission]. (1995) (0)
Activity of antibodies to hepatitis C virus of patients with chronic non-A, non-B hepatitis decreases during interferon α therapy (1991) (0)
The Reference Panel of Japan for Evaluation of (2012) (0)
Reply to “Poliovirus-Neutralization Test with Poliovirus Pseudovirus To Measure Neutralizing Antibody in Humans” (2012) (0)
Viral and Immunological Characteristics of COVID-19 Vaccine Breakthrough Infections (2021) (0)
Characterization and modification of anti-occludin monoclonal antibodies that inhibit HCV infection (2017) (0)
2) Li TC, Yoshizaki S, Ami Y, Suzaki Y, Yasuda SP, (2013) (0)
Two strategies underlying the trade-off of hepatitis C virus proliferation: stay-at-home or leaving-home? (2019) (0)
641 Efficient replication of hepatitis C virus genotype 2A subgenomic replicon isolated from fulminant hepatitis patients (2003) (0)
Galectin-9 restricts hepatitis B virus replication via p62/SQSTM1-mediated selective autophagy of viral core proteins (2022) (0)
In vitro production of antimitochondrial antibody by peripheral blood mononuclear cells in patients with primary biliary cirrhosis. (1991) (0)
Development of a Particle Agglutination Method with Soluble Virus Receptor for Identiﬁcation of Poliovirus (cid:1) (2010) (0)
N6-methyladenosine Modification of Hepatitis B Virus RNA in the Coding Region of HBx (2023) (0)
Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication (2017) (0)
Involvement of PUF60 in Transcriptional and Post-transcriptional Regulation of Hepatitis B Virus Pregenomic RNA Expression (2017) (0)
About anti-HCV activity mechanism of Guanfacine, a sympatholytic drug. (2017) (0)
NOTES Nonhepatic Cell Lines HeLa and 293 Support Efﬁcient Replication of the Hepatitis C Virus Genotype 2a Subgenomic Replicon (2004) (0)
miR-27b-mediated suppression of aquaporin-11 expression in hepatocytes reduces HCV genomic RNA levels but not viral titers (2019) (0)
Development of large-area amorphous silicon solar cells (1985) (0)
A Nanoimaging Approach for Identification of the Secondary Structural Domains in Long ssRNA Molecules (2018) (0)
Structural basis for the RNA-dependent assembly pathway of hepatitis E virion-sized particles (2010) (0)
Vaccines against hepatitis B and C virus (1995) (0)
Specific inhibition of hepatitis C virus gene expression by antisense oligonucleotides in a tightly regulated cell culture system (1995) (0)
Subject Index, Vol. 44, 1989 (1989) (0)
Correction to: Required concentration index quantifies effective drug combinations against hepatitis C virus infection (2021) (0)
Hepatitis C virus induced degradation of cell death-inducing DFFA-like effector B 1 leads to hepatic lipid dysregulation 2 3 (2016) (0)
BPB Reports (2021) (0)
A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19 (2023) (0)
Inhibition par oligonucleotides antisens du virus de l'hepatite c (1995) (0)
Correction to: Required concentration index quantifies effective drug combinations against hepatitis C virus infection (2021) (0)
Comparative characterization of human hepatoma-derived Huh7.5.1-8 cells and African green monkey kidney-derived Vero cells in Japanese encephalitis virus production (2017) (0)
Modified genomic rna of the human hepatitis C virus with autonomous replication competence (2005) (0)
Nucleic acid construction containing the hepatitis c (hcv) virus of the nucleic acid of genomic origin of genotipo 2a and cell that has the nucleic acid construction transferred to the inside. (2003) (0)
Human sapovirus classification based on complete capsid nucleotide sequences (2011) (0)
Will Vitamin D Supplementation Have a Role in the Treatment of Patients with Chronic Hepatitis C (2012) (0)
Hepatitis C Virus Replikation sensitiviert humane Hepatomazellen auf TRAIL-induzierte Apoptose (2008) (0)
Compoundsof Minor Enviroxime-Like Oxysterol-Binding Protein Family I Is the (2014) (0)
449 Hepatitis C virus structural proteins and activation of Toll-like receptors 2 and 4 (2006) (0)
CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection (2014) (0)
Expression of a functional intrabody against hepatitis C virus core protein in Escherichia coli and silkworm pupae. (2018) (0)
O.192 Scavenger receptor class B type I is a co-receptor for infection with cell culture-derived hepatitis C virus (2006) (0)
Tumor vaccination against hepatoma: How does it work? (1994) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Takaji Wakita?

Takaji Wakita is affiliated with the following schools:

Hokkaido University
University of Tokyo
Nagoya University
Osaka University
Kyoto University

Takaji Wakita's Academic­Influence.com Rankings

Takaji Wakita's Degrees

Why Is Takaji Wakita Influential?

Takaji Wakita's Published Works

Published Works

What Schools Are Affiliated With Takaji Wakita?

Takaji Wakita's AcademicInfluence.com Rankings